Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
MUC1 Vaccine + PolyICLC for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial will test a new vaccine for people with non-small cell lung cancer. The vaccine will be given every 3 weeks for 3 doses, and then yearly for up to 5 years for people who respond well to the vaccine.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.